77 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • Biohaven Pharmaceutical Holding Company Ltd. BHVN shares jumped 70.8% to $142.01. Pfizer Inc PFE will acquire Biohaven Pharmaceutical Holding for $148.50 per share, equivalent to $11.6 billion.
  • Vroom, Inc. VRM shares gained 38.4% to $1.4950 after the company reported better-than-expected Q1 results.
  • Appian Corporation APPN gained 34.5% to $57.86. Appian was awarded $2.036 billion in damages against Pegasystems Inc..
  • AdaptHealth Corp. AHCO shares climbed 25.9% to $14.39 after the company reported upbeat Q1 sales and announced a $200 million buyback.
  • CECO Environmental Corp. CECE gained 24.7% to $5.30 after the company posted upbeat Q1 results and announced the purchase of Compass Water Solutions.
  • Assertio Holdings, Inc. ASRT rose 23.1% to $2.3150 after the company reported better-than-expected Q1 EPS and sales results.
  • Aurinia Pharmaceuticals Inc. AUPH gained 22.2% to $10.93 following strong quarterly sales.
  • ShockWave Medical, Inc. SWAV jumped 21.1% to $140.38 after the company reported better-than-expected Q1 results and raised its FY22 sales guidance to above analyst estimates.
  • FibroGen, Inc. FGEN gained 20.2% to $9.55 after the company reported better-than-expected Q1 EPS results.
  • The Pennant Group, Inc. PNTG jumped 19.7% to $15.32 following strong quarterly results.
  • Myovant Sciences Ltd. MYOV gained 19% to $9.26 following Q4 earnings.
  • Intra-Cellular Therapies, Inc. ITCI gained 18.6% to $50.97 after reporting narrower-than-expected quarterly loss.
  • Angi Inc. ANGI jumped 18% to $4.2350 following upbeat quarterly sales.
  • Cyngn Inc. CYN gained 17.8% to $5.01.
  • Cara Therapeutics, Inc. CARA gained 17.7% to $8.77 after reporting upbeat quarterly results.
  • Y-mAbs Therapeutics, Inc. YMAB jumped 16.8% to $9.61 following narrower-than-expected quarterly loss.
  • Park-Ohio Holdings Corp. PKOH gained 16.6% to $11.50 after the company reported better-than-expected Q1 sales results and EPS results were higher year over year.
  • Haemonetics Corporation HAE gained 16.5% to $57.41 following better-than-expected quarterly results.
  • Nuvation Bio Inc. NUVB jumped 16.1% to $4.91 after the company posted a narrower quarterly loss.
  • Cronos Group Inc. CRON rose 14.4% to $3.24 following Q1 results.
  • Cortexyme, Inc. CRTX gained 14% to $3.74. Cortexyme agreed to acquire privately held Novosteo, which is focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
  • Coupang, Inc. CPNG jumped 13.3% to $10.60.
  • OPKO Health, Inc. OPK jumped 12.7% to $2.75 following Q1 results.
  • Seagen Inc. SGEN gained 12.2% to $122.25. The Board of Directors of Seagen announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence.
  • Color Star Technology Co., Ltd. CSCW rose 12.1% to $0.1278 after dropping 12% on Monday.
  • Nutex Health, Inc. NUTX rose 11.4% to $5.18 after declining 22% on Monday.
  • LivePerson, Inc. LPSN rose 10.9% to $18.08 following Q1 results.
  • NeuroBo Pharmaceuticals, Inc. NRBO rose 9.5% to $0.5113 after tumbling 23% on Monday.
  • Evolve Transition Infrastructure LP SNMP rose 7.8% to $0.4398 after declining around 7% on Monday.
  • Cenntro Electric Group Limited CENN rose 7.1% to $1.5850. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
  • Clover Health Investments, Corp. CLOV rose 5.4% to $2.54 after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.

 

Losers

  • Upstart Holdings, Inc. UPST shares dipped 56.7% to $33.38 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
  • Kaleyra, Inc. KLR dipped 38.8% to $3.7250 after the company reported worse-than-expected Q1 EPS and sales results and issued Q2 and FY22 sales guidance below analyst estimates.
  • United Insurance Holdings Corp. UIHC fell 38.5% to $1.3770 after the company reported a wider Q1 core loss.
  • Embark Technology, Inc. EMBK dropped 37.8% to $2.1696.
  • Cipher Mining Inc. CIFR fell 36.2% to $2.06. Cipher Mining posted a Q1 loss of $0.07 per share.
  • Desktop Metal, Inc. DM dropped 35.3% to $2.2101 following wider-than-expected quarterly loss.
  • Akanda Corp. AKAN dipped 28% to $1.6291.
  • FutureFuel Corp. FF fell 28.7% to $7.04 after the company said Q1 EPS results were lower year over year.
  • Diebold Nixdorf, Incorporated DBD fell 28% to $2.7350 after the company posted downbeat quarterly results and lowered sales guidance.
  • Enochian Biosciences, Inc. ENOB fell 27.8% to $4.65.
  • Tenon Medical, Inc. TNON fell 26.8% to $36.42.
  • Bausch Health Companies Inc. BHC fell 26.4% to $9.49 after the company reported Q1 sales results were down year over year and cut FY22 guidance.
  • Huadi International Group Co., Ltd. HUDI dipped 26.4% to $21.20.
  • GoodRx Holdings, Inc. GDRX shares fell 25.7% to $7.99 after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates.
  • National Vision Holdings, Inc. EYE dropped 25.4% to $25.04 as the company lowered FY22 guidance.
  • FTC Solar, Inc. FTCI fell 24.9% to $2.4699 following downbeat quarterly results.
  • CarGurus, Inc. CARG fell 24.4% to $22.56 after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates.
  • Spark Networks SE LOV dipped 20.7% to $1.64 following Q1 results.
  • loanDepot, Inc. LDI dropped 20.3% to $2.15 as the company swung to a loss in the first quarter.
  • Cvent Holding Corp. CVT fell 19.6% to $4.3050 following Q1 results.
  • AppFolio, Inc. APPF dipped 18.8% to $80.99 after reporting a loss for the first quarter.
  • Infrastructure and Energy Alternatives, Inc. IEA dropped 18.3% to $7.01 following wider-than-expected quarterly loss.
  • LogicBio Therapeutics, Inc. LOGC fell 17.8% to $0.5487. LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
  • StarTek, Inc. SRT declined 17.2% to $3.3350 following Q1 results.
  • TaskUs, Inc. TASK dropped 16.4% to $19.50 following Q1 results.
  • Wejo Group Limited WEJO declined 16.2% to $2.18.
  • Babcock & Wilcox Enterprises, Inc. BW fell 16% to $5.96 following wider-than-expected quarterly loss.
  • FreightCar America, Inc. RAIL dropped 15.4% to $4.29 after reporting Q1 loss.
  • Village Farms International, Inc. VFF dipped 15.1% to $3.26 following weak quarterly results.
  • Benson Hill, Inc. BHIL fell 14.6% to $2.4550.
  • Local Bounti Corporation LOCL declined 14.5% to $4.40 following Q1 results.
  • Lightwave Logic, Inc. LWLG fell 14.4% to $8.02.
  • Eve Holding Inc. EVEX dropped 14.3% to $9.70. Eve Holding reported that its common stock will begin trading on NYSE today under the symbol 'EVEX.'
  • Science 37 Holdings, Inc. SNCE dropped 14% to $3.19. Science 37 Holdings reported better-than-expected Q1 EPS and sales results.
  • Starry Group Holdings, Inc. STRY fell 14% to $7.22.
  • Dave Inc. DAVE dipped 13.3% to $2.29.
  • Vivid Seats Inc. SEAT dropped 12.7% to $7.52 following Q1 results.
  • Veeco Instruments Inc. VECO fell 11.8% to $20.08 after the company issued weak earnings forecast.
  • Matrix Service Company MTRX dropped 11.6% to $5.74 following wider Q3 loss.
  • TrueCar, Inc. TRUE fell 11.5% to $3.13. TrueCar posted a Q1 net loss of $12.4 million.
  • Aterian, Inc. ATER shares fell 11.5% to $3.5301 after the company reported worse-than-expected Q1 sales results.
  • Affirm Holdings, Inc. AFRM fell 11.4% to $18.25 after Upstart reported financial results and issued guidance below analyst estimates.
  • Revlon, Inc. REV fell 11.4% to $4.5093. Revlon recently posted a Q1 loss of $1.14 per share.
  • Groupon, Inc. GRPN fell 10.6% to $13.99 after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance.
  • Novavax, Inc. NVAX fell 9.5% to $48.19 as the company posted downbeat results for its first quarter on Monday.
  • Blue Water Vaccines, Inc. BWV fell 7.8% to $4.9999 after jumping 44% on Monday.

 

 

 

 

Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day Movers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...